Coming Soon: FDA Over-The-Counter Drug Approval Overhaul

By Rebecca Dandeker, Ann Begley, Kathleen Sanzo and Suzanne Bassett (December 17, 2018, 3:16 PM EST) -- A new pathway for over-the-counter products could be on the horizon, as both houses of Congress have proposed bills to revise the U.S. Food and Drug Administration's procedures to allow OTC medications to be marketed, and to permit the FDA to collect user fees, potentially expediting a newly created OTC drug review process. The FDA is preparing for an eventual passage of the law, and so should OTC drug manufacturers and private label distributors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!